Pathophysiology of sickle cell disease

P Sundd, MT Gladwin, EM Novelli - Annual review of pathology …, 2019 - annualreviews.org
Since the discovery of sickle cell disease (SCD) in 1910, enormous strides have been made
in the elucidation of the pathogenesis of its protean complications, which has inspired recent …

Selectins: initiators of leucocyte adhesion and signalling at the vascular wall

RP McEver - Cardiovascular research, 2015 - academic.oup.com
The selectins are transmembrane, Ca2+-dependent lectins that mediate leucocyte rolling on
vascular surfaces, the first adhesive step during inflammation and immune surveillance …

[HTML][HTML] Crizanlizumab for the prevention of pain crises in sickle cell disease

KI Ataga, A Kutlar, J Kanter, D Liles… - … England Journal of …, 2017 - Mass Medical Soc
Background The up-regulation of P-selectin in endothelial cells and platelets contributes to
the cell–cell interactions that are involved in the pathogenesis of vaso-occlusion and sickle …

P-selectin promotes neutrophil extracellular trap formation in mice

J Etulain, K Martinod, SL Wong… - Blood, The Journal …, 2015 - ashpublications.org
Neutrophil extracellular traps (NETs) can be released in the vasculature. In addition to
trap** microbes, they promote inflammatory and thrombotic diseases. Considering that P …

Aptamers from cell-based selection for bioanalytical applications

W Tan, MJ Donovan, J Jiang - Chemical reviews, 2013 - ACS Publications
Nucleic acids are the foundation of life. Specific sequences translate certain genetic traits,
protein expression, and, ultimately, cellular function. Yet, nucleic acids not only store genetic …

Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies

D Manwani, PS Frenette - Blood, The Journal of the American …, 2013 - ashpublications.org
Recurrent and unpredictable episodes of vaso-occlusion are the hallmark of sickle cell
disease. Symptomatic management and prevention of these events using the fetal …

Inflammation in sickle cell disease

N Conran, JD Belcher - Clinical hemorheology and …, 2018 - content.iospress.com
The primary β-globin gene mutation that causes sickle cell disease (SCD) has significant
pathophysiological consequences that result in hemolytic events and the induction of the …

Therapeutic strategies for sickle cell disease: towards a multi-agent approach

MJ Telen, P Malik, GM Vercellotti - Nature reviews Drug discovery, 2019 - nature.com
For over 100 years, clinicians and scientists have been unravelling the consequences of the
A to T substitution in the β-globin gene that produces haemoglobin S, which leads to the …

Anemia: progress in molecular mechanisms and therapies

VG Sankaran, MJ Weiss - Nature medicine, 2015 - nature.com
Anemia is a major source of morbidity and mortality worldwide. Here we review recent
insights into how red blood cells (RBCs) are produced, the pathogenic mechanisms …

Design of a multifunctional nanozyme for resolving the proinflammatory plaque microenvironment and attenuating atherosclerosis

H He, Q Han, S Wang, M Long, M Zhang, Y Li… - ACS …, 2023 - ACS Publications
Persistent inflammation within atherosclerotic plaques is a crucial factor contributing to
plaque vulnerability and rupture. It has become increasingly evident that the …